how do glp-1 drugs work for weight loss medications GLP-1 Medications Infographic | Medidex

Description

Dose-by-dose weight loss in Phase 2 (NEJM) Phase 2 NEJM weight loss by dose, 24 and 48 weeks Dose 1 mg 24 weeks -7.2% 48 weeks -8.7% Dose 4 mg 24 weeks -12.9% 48 weeks -17.5% Dose 8 mg 24 weeks -15.7% 48 weeks -22.8% Dose 12 mg 24 weeks -17.5% 48 weeks -24.2% Dose Placebo 24 weeks -1.6% 48 weeks -2.1% Source: Jastreboff et al., NEJM 2023

It produces beneficial effects if administered for short periods, because raising peripheral insulin levels acutely increases insulin levels in the brain and cerebrospinal fluid (CSF) (1719)

Despite these limitations, this early analysis provides timely insight into who is receiving oral semaglutide for obesity immediately following approval and demonstrates the value of real-world data for monitoring new drug uptake in near real time

Signs and symptoms of low blood sugar may include dizziness or light-headedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jittery dehydration leading to kidney problems